The latest pharmaceutical merger is necessarily a risk but is also an opportunity.
Article PDF
Rights and permissions
About this article
Cite this article
Glaxo and Wellcome. Nature 374, 292 (1995). https://doi.org/10.1038/374292a0
Issue Date:
DOI: https://doi.org/10.1038/374292a0